Detalles de la búsqueda
1.
Necitumumab plus gemcitabine and cisplatin in previously treated lung squamous cell carcinoma.
Invest New Drugs
; 41(1): 168-172, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36331673
2.
Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
Ann Surg Oncol
; 28(6): 3046-3054, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33084992
3.
Pulmonary Resection for a Residual Tumor after Definitive Radiation in Locally Advanced Non-Small Cell Lung Cancer.
Thorac Cardiovasc Surg
; 66(2): 170-173, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27575277
4.
BioKnife, a uPA activity-dependent oncolytic Sendai virus, eliminates pleural spread of malignant mesothelioma via simultaneous stimulation of uPA expression.
Mol Ther
; 20(4): 769-77, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22314292
5.
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.
JTO Clin Res Rep
; 4(12): 100593, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38046378
6.
Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.
Surg Today
; 42(10): 934-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22864936
7.
Artificial intelligence-derived gut microbiome as a predictive biomarker for therapeutic response to immunotherapy in lung cancer: protocol for a multicentre, prospective, observational study.
BMJ Open
; 12(6): e061674, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35676015
8.
Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation.
Front Oncol
; 12: 965741, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36313664
9.
Dedifferentiated chondrosarcoma of the lung: report of a case.
Surg Today
; 41(2): 251-4, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21264763
10.
Effectiveness of erlotinib against recurrent pulmonary adenocarcinoma unresponsive to gefitinib: report of a case.
Surg Today
; 41(2): 255-7, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21264764
11.
Assessing a clinical pathway to improve the quality of care in pulmonary resections.
Surg Today
; 41(6): 787-90, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21626323
12.
The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma.
Surg Today
; 41(6): 818-23, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21626329
13.
Anti-PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status.
Onco Targets Ther
; 14: 1961-1968, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33762828
14.
Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy.
Thorac Cancer
; 12(23): 3286-3289, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34689423
15.
Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue.
Front Oncol
; 11: 704084, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34497761
16.
Clinical course and prognosis of patients with lung cancer who develop anticancer therapy-related pneumonitis.
J Cancer Res Clin Oncol
; 147(6): 1857-1864, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33387034
17.
Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation.
Thorac Cancer
; 12(6): 978-980, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33533182
18.
Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab.
Thorac Cancer
; 12(14): 2122-2125, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002950
19.
Clinical utility of pretreatment Glasgow prognostic score in non-small-cell lung cancer patients treated with immune checkpoint inhibitors.
Lung Cancer
; 152: 27-33, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33341085
20.
Prognostic impact of local treatment against postoperative oligometastases in non-small cell lung cancer.
J Surg Oncol
; 102(7): 852-5, 2010 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20886558